SCHEMBL12875949

SCHEMBL12875949

Cc1cccc(-c2nc(CO)c(C3CC3)s2)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PPARG P37231 1/20 0.41
▸ PPARA Q07869 1/20 0.41
▸ ALDH1A1 P00352 2/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ KMT2A Q03164 1/20 0.40
▸ TRPM8 Q7Z2W7 1/20 0.40
▸ NPC1 O15118 1/20 0.40
▸ PKM P14618 1/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ ADORA3 P0DMS8 1/20 0.39
▸ HRH3 Q9Y5N1 1/20 0.37
▸ CASP3 P42574 1/20 0.37
▸ SENP7 Q9BQF6 1/20 0.37
▸ SENP6 Q9GZR1 1/20 0.37
▸ MAPT P10636 2/20 0.37
▸ CCNA2 P20248 1/20 0.36
▸ CDK2 P24941 1/20 0.36
▸ CCNA1 P78396 1/20 0.36
▸ LMNA P02545 4/20 0.36
▸ IDO1 P14902 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12876884 0.87 MEN1 (0.40) PPARGPPARAALDH1A1MEN1KMT2A
SCHEMBL1198708 0.81 MEN1 (0.47) PPARGPPARAALDH1A1MEN1KMT2A
SCHEMBL12876889 0.81 PPARG (0.44) PPARGPPARAALDH1A1TRPM8NPC1
SCHEMBL12876887 0.80 MAPT (0.45) PPARGPPARAALDH1A1MEN1KMT2A
SCHEMBL12875931 0.80 ALDH1A1 (0.46) PPARGPPARAALDH1A1MEN1KMT2A
SCHEMBL12875944 0.79 L3MBTL1 (0.46) PPARGPPARAALDH1A1TRPM8NPC1
SCHEMBL12875870 0.78 ALDH1A1 (0.44) PPARGPPARAALDH1A1MEN1KMT2A
SCHEMBL12875849 0.77 DCK (0.46) ALDH1A1MEN1KMT2ATRPM8ADORA3
SCHEMBL12875963 0.76 PPARG (0.39) PPARGPPARAALDH1A1TRPM8NPC1
SCHEMBL12876152 0.76 MAPT (0.43) ALDH1A1MEN1KMT2ATRPM8ADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8461348-B2 Heterocyclic derivative and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2013-06-11 — — US disclosed
US-20110028493-A1 HETEROCYCLIC DERIVATIVE AND USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-02-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110028493-A1 HETEROCYCLIC DERIVATIVE AND USE THEREOF PDE3B, PDE5A, PDE2A PPARG 139/4885PPARA 517/4885ALDH1A1 1037/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback